In accordance with the Minimal Information for Studies of EVs 2024 (MISEV) [21], several known EV markers, including CD9, CD81, Flotillin-1, and TSG101, were observed in the purified serum EVs of patients with lung cancer and healthy individuals. This evidence concerns the gene CD9 and lung carcinoma.